GlycoMimetics Inc (NASDAQ:GLYC)

8.34
Delayed Data
As of Mar 04
 -0.07 / -0.83%
Today’s Change
6.02
Today|||52-Week Range
18.99
+15.83%
Year-to-Date

Today’s Trading

Previous close8.41
Today’s open8.41
Day’s range8.09 - 8.41
Volume26,057
Average volume (3 months)30,442
Market cap$158.9M
Dividend yield--
Data as of 3:55pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)-272.73%
Earnings growth (this year)+95.08%
Earnings growth (next 5 years)--
Revenue growth (last year)-73.83%
P/E ratioNM
Price/Sales--
Price/Book54.39

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll AG-0.49-6.13%
ASMBAssembly Biosciences...-0.52-3.51%
CRMECardiome Pharma Corp-0.11-1.11%
MDWDMediwound Ltd+0.27+3.54%
Data as of 3:59pm ET, 03/04/2015

Financials

Last reporting dateMarch 5, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$4.0M
Annual profit (last year)-$10.6M
Net profit margin-265.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer &
Head-Media Relations
Brian M. Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account